• AstraZeneca Settles Nexium, Prilosec Product Liability Litigations; To Pay $425 Mln

    来源: NASDAQ US Markets / 03 10月 2023 03:04:52   America/New_York

    (RTTNews) - British drug major AstraZeneca Plc (AZN.L, AZN) announced Tuesday that it has entered into settlement agreements in the product liability litigations related to Nexium and Prilosec. The specific terms of the agreements are confidential. https://www.nasdaq.com/articles/astrazeneca-settles-nexium-prilosec-product-liability-litigations-to-pay-$425-mln
分享